Anika Therapeutics Inc. (ANIK)

AI Score

Unlock

13.93

-0.09 (-0.64%)

At close: Apr 21, 2025, 12:25 PM

Anika Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	-1.29M	38.75M	41.92M	40.52M	42.97M	41.47M	44.3M	37.92M	39.62M	40.26M	39.66M	36.69M	35.82M	39.54M	38.15M	34.29M	32.69M	31.69M	30.68M	35.4M	29.77M	29.7M	30.42M	24.72M	26.96M	26.79M	30.55M	21.26M	29.39M	27.18M	33.46M	23.39M	28.73M	25.79M	26.58M	22.28M
Cost of Revenue	-23.86M	37.31M	14.56M	15.89M	16.64M	16.52M	15.33M	15.08M	15.49M	17.48M	14.79M	14.89M	17.69M	16.51M	17.33M	13.32M	15.94M	14.35M	16.94M	14.2M	8.65M	5.95M	6.84M	7.31M	7M	8.28M	8.15M	7.84M	8.72M	6.25M	6.32M	6.08M	7.54M	5M	6.07M	5.42M
Gross Profit	22.57M	1.44M	27.36M	24.63M	26.33M	24.94M	28.97M	22.84M	24.13M	22.78M	24.86M	21.8M	18.13M	23.02M	20.81M	20.97M	16.75M	17.34M	13.74M	21.2M	21.12M	23.75M	23.58M	17.41M	19.95M	18.5M	22.4M	13.42M	20.67M	20.93M	27.15M	17.3M	21.19M	20.79M	20.52M	16.86M
Operating Income	27.82M	-28.02M	161K	-5.06M	-1.59M	-7.67M	-3.63M	-12.55M	-6.67M	-5.8M	-3.38M	-3.55M	-9.12M	1.3M	9.18M	1.26M	-17.95M	-7.93M	-9.54M	4.99M	4.8M	12.05M	11.91M	5.48M	9.76M	8.57M	11.25M	-7.83M	9.73M	10.27M	17.73M	8.01M	12.74M	13.69M	13.47M	10.71M
Interest Income	n/a	406K	n/a	n/a	577K	635K	561K	n/a	276K	436K	n/a	n/a	n/a	n/a	n/a	n/a	116K	72K	31K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	28.56M	-27.61M	756K	-4.47M	-63.2M	-7.04M	-3.07M	-12.01M	-6.39M	-5.36M	-3.29M	-3.71M	-9.17M	1.25M	9.13M	1.22M	-18.14M	-8.15M	-9.71M	5.27M	5.16M	12.53M	12.45M	5.98M	10.31M	9.1M	11.54M	-7.74M	9.87M	10.53M	17.74M	8.06M	12.79M	13.78M	13.52M	10.78M
Net Income	-21.86M	-29.92M	-88K	-4.51M	-63M	-6.58M	-2.74M	-10.35M	-4.91M	-4.17M	-2.84M	-2.93M	-5.79M	558K	6.53M	2.84M	-15.66M	-6.41M	-7.71M	3.46M	4.05M	9.2M	9.44M	4.51M	7.72M	7.6M	10.09M	-6.69M	8.07M	6.89M	11.37M	5.49M	8.09M	8.95M	8.62M	6.89M
Selling & General & Admin	-4.89M	19.11M	19.81M	21.53M	20.34M	24.83M	23.69M	27M	23.05M	21.28M	21.27M	19.2M	20.43M	17.5M	17.99M	18.18M	15.18M	15.9M	14.55M	14.43M	12.24M	7.54M	7.5M	7.67M	6.13M	5.7M	6.42M	16.09M	6.68M	4.82M	4.97M	5.07M	5.49M	4.28M	4.25M	3.99M
Research & Development	2.74M	7.24M	7.4M	8.16M	7.58M	7.79M	8.91M	8.4M	7.75M	7.3M	6.97M	6.16M	6M	7.67M	7.29M	6.36M	7.63M	5.22M	4.53M	6.05M	4.08M	4.16M	4.17M	4.26M	4.06M	4.23M	4.73M	5.16M	4.27M	5.84M	4.45M	4.23M	2.96M	2.82M	2.79M	2.16M
Other Expenses	-3.1M	3.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13.85M	4.15M	4.2M	n/a	28.75M	n/a	n/a	n/a	31.28M	n/a	n/a	n/a	27.36M	n/a	n/a	n/a	24.03M	n/a	n/a	n/a
Operating Expenses	-5.25M	29.46M	27.2M	29.69M	27.92M	32.62M	32.6M	35.4M	30.8M	28.58M	28.24M	25.36M	26.43M	25.17M	25.28M	24.54M	22.81M	21.12M	19.08M	20.48M	16.32M	11.7M	11.67M	11.93M	10.19M	9.93M	11.15M	21.25M	10.94M	10.66M	9.42M	9.3M	8.45M	7.1M	7.05M	6.15M
Interest Expense	n/a	n/a	n/a	592K	1.21M	n/a	561K	n/a	276K	436K	96K	n/a	n/a	n/a	n/a	n/a	300K	300K	200K	279K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-29.11M	66.77M	41.76M	45.59M	44.56M	49.14M	47.93M	50.48M	46.29M	46.06M	43.04M	40.25M	44.12M	41.69M	42.62M	37.85M	38.75M	35.47M	36.02M	34.68M	24.97M	17.65M	18.5M	19.24M	17.19M	18.21M	19.3M	29.1M	19.66M	16.91M	15.74M	15.38M	15.99M	12.1M	13.11M	11.57M
Income Tax Expense	2.87M	2.31M	844K	43K	-204K	-463K	-329K	-1.66M	-1.48M	-1.19M	-442K	-775K	-3.38M	694K	2.6M	-1.62M	-2.48M	-1.74M	-2M	1.81M	1.11M	3.33M	3.01M	1.47M	2.6M	1.5M	1.45M	-1.05M	1.8M	3.64M	6.37M	2.57M	4.7M	4.83M	4.9M	3.89M
Shares Outstanding (Basic)	14.72M	14.77M	14.84M	14.7M	14.65M	14.63M	14.69M	14.58M	14.64M	14.4M	14.21M	14.47M	14.37M	14.43M	14.39M	14.34M	14.28M	14.21M	14.2M	14.2M	14.28M	14.07M	13.92M	14.19M	14.17M	14.24M	14.65M	14.53M	14.6M	14.58M	14.59M	14.58M	14.54M	14.63M	14.68M	14.88M
Shares Outstanding (Diluted)	14.72M	14.77M	14.84M	14.7M	14.65M	14.63M	14.69M	14.65M	14.64M	14.6M	14.55M	14.47M	14.44M	14.65M	14.63M	14.44M	14.28M	14.21M	14.2M	14.35M	14.62M	14.39M	14.09M	14.31M	14.3M	14.38M	14.91M	14.68M	15.14M	15.12M	15.04M	15.04M	14.98M	15.08M	15.11M	15.31M
EPS (Basic)	-1.49	-2.03	-0.01	-0.31	-4.3	-0.45	-0.19	-0.71	-0.34	-0.29	-0.2	-0.2	-0.4	0.04	0.45	0.20	-1.1	-0.45	-0.54	0.41	0.28	0.65	0.68	0.32	0.54	0.53	0.69	-0.46	0.55	0.47	0.78	0.38	0.56	0.61	0.59	0.46
EPS (Diluted)	-1.49	-2.03	-0.01	-0.31	-4.3	-0.45	-0.19	-0.71	-0.34	-0.29	-0.2	-0.2	-0.4	0.04	0.45	0.20	-1.1	-0.45	-0.54	0.40	0.28	0.64	0.67	0.31	0.54	0.53	0.68	-0.46	0.53	0.46	0.76	0.37	0.54	0.59	0.57	0.45
EBITDA	26.53M	-25.42M	2.22M	-1.87M	1.98M	-4.13M	-81K	-9M	-3M	-2.3M	328K	63K	-4.57M	5.24M	-967K	1.26M	-2.57M	-273K	-1.64M	8.23M	6.33M	13.56M	14.21M	5.48M	11.24M	10.09M	12.69M	-6.26M	10.79M	11.47M	18.73M	9.02M	13.7M	14.56M	14.43M	11.65M
EBIT	24.72M	-27.61M	756K	-4.47M	-63.2M	-7.67M	-3.63M	-12.55M	-6.67M	-5.8M	-3.38M	-3.55M	-9.17M	1.25M	9.13M	-3.56M	-17.84M	-3.78M	-9.51M	716K	4.8M	12.05M	12.45M	5.98M	9.76M	8.57M	11.54M	-7.74M	9.73M	10.27M	17.73M	8.06M	12.74M	13.69M	13.47M	10.71M
Depreciation & Amortization	1.81M	2.19M	2.06M	2.6M	3.59M	4.04M	4.15M	3.55M	4.25M	3.97M	2.16M	2.08M	4.09M	3.99M	4.01M	3.91M	3.5M	3.5M	3.7M	2.76M	1.53M	1.52M	1.17M	1.77M	1.48M	1.51M	1.45M	1.47M	1.07M	1.2M	1.01M	1.01M	957K	876K	959K	942K